載入...
Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
[Image: see text] Tolvaptan is an effective drug for the treatment of autosomal dominant polycystic kidney disease, but its use is associated with a significant risk of liver injury in a small number of patients. Herein we describe the presence of tolvaptan- and tolvaptan-metabolite-responsive T cel...
Na minha lista:
| 發表在: | Chem Res Toxicol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Chemical
Society
2020
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672698/ https://ncbi.nlm.nih.gov/pubmed/33085478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.chemrestox.0c00328 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|